✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹3,408 Cr.
P/E
27.05
About
Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs, Home Diagnostics, Formulations and OTC products. The plant at Masulkhana is for manufacture of Loratadine, an anti-al… Read more
Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs, Home Diagno… Read more
Low
42
52W Range
High
101
  • Morepen Laboratories
  • Aarti Drugs
  • Solara Active Pharma
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

11 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share
0 %
(as of Jul 22)
Anti - Diabetes - Market Share
0.07 %
(as of Jul 22)
Anti-Infectives - Market Share
1.58 %
(as of May 19)
Blood Related - Market Share
0 %
(as of Jul 22)
Cardiovascular - Market Share
0.04 %
(as of Nov 21)
Dermatology - Market Share
0.05 %
(as of Jul 22)
Gastro-Intestinal - Market Share
Revenue mix

Product Wise Break-Up

Product Wise Break-Up - Home Diagnostics / Health

Product Wise Break-Up - Active Pharmaceutical Ingredients (API) & Intermediates

Product Wise Break-Up - Finished Formulations

Location Wise Break-Up

Therapeutic Area Break-Up - Active Pharmaceutical Ingredients (API) & Intermediates

Operational Metrics

    Select a Metric
    • Global DMFs filed (.)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Burnol
    Customers
    • Novartis India Ltd.
    FAQs on Morepen Laboratories Ltd. Business

    Morepen Laboratories is a pharmaceutical company manufacturing APis, Home Diagnostics, and OTC products. They specialize in anti-allergy drug Loratadine and are prominent in Blood Glucose Monitors and Blood Pressure Monitors domestically.

    Morepen Laboratories major competitors are Aarti Drugs, Solara Active Pharma, IOL Chem & Pharma, Bajaj Healthcare, SMS Pharmaceuticals, Hester Biosciences, Themis Medicare.
    Market Cap of Morepen Laboratories is ₹2,983 Crs.
    While the median market cap of its peers are ₹1,972 Crs.

    Morepen Laboratories seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Investor Presentation Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call Mar Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary Mar Mar Jun Jun Sep Dec Mar Jun Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material